SIG
JNJ icon

Sargent Investment Group’s Johnson & Johnson JNJ Stock Holding History

Sargent Investment Group’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.1M Buy
33,131
+78
+0.2% +$18.2K 1.07% 22
2025
Q4 		$6.84M Buy
33,053
+8,306
+34% +$1.64M 0.86% 27
2025
Q3 		$4.59M Sell
24,747
-71
-0.3% -$12.2K 0.65% 39
2025
Q2 		$4.23M Buy
24,818
+117
+0.5% +$18K 0.57% 36
2025
Q1 		$4.1M Buy
24,701
+3,692
+18% +$578K 0.65% 33
2024
Q4 		$3.04M Sell
21,009
-432
-2% -$66.9K 0.5% 42
2024
Q3 		$3.47M Sell
21,441
-338
-2% -$53.9K 0.62% 39
2024
Q2 		$3.18M Buy
21,779
+436
+2% +$64.8K 0.65% 38
2024
Q1 		$3.38M Sell
21,343
-4,046
-16% -$644K 0.74% 33
2023
Q4 		$3.98M Sell
25,389
-628
-2% -$96.3K 0.87% 31
2023
Q3 		$4.05M Buy
26,017
+1,746
+7% +$288K 0.98% 25
2023
Q2 		$4.02M Sell
24,271
-615
-2% -$99.3K 0.98% 29
2023
Q1 		$3.9M Sell
24,886
-808
-3% -$130K 1.03% 26
2022
Q4 		$4.54M Buy
25,694
+85
+0.3% +$14.7K 1.41% 17
2022
Q3 		$4.15M Buy
25,609
+145
+0.6% +$24.5K 1.29% 22
2022
Q2 		$4.52M Buy
25,464
+125
+0.5% +$22.3K 1.4% 22
2022
Q1 		$4.49M Buy
25,339
+700
+3% +$119K 1.13% 24
2021
Q4 		$4.21M Sell
24,639
-1,348
-5% -$221K 0.96% 28
2021
Q3 		$4.2M Buy
25,987
+1,056
+4% +$180K 1.02% 31
2021
Q2 		$4.11M Sell
24,931
-130
-0.5% -$21.5K 0.97% 29
2021
Q1 		$4.12M Buy
25,061
+2,782
+12% +$450K 1.08% 24
2020
Q4 		$3.51M Buy
22,279
+590
+3% +$87.1K 1.11% 24
2020
Q3 		$3.23M Buy
21,689
+1,152
+6% +$170K 1.18% 22
2020
Q2 		$2.88M Buy
20,537
+175
+0.9% +$25.5K 1.08% 25
2020
Q1 		$2.67M Buy
20,362
+379
+2% +$53.8K 1.23% 22
2019
Q4 		$2.92M Buy
19,983
+133
+0.7% +$18K 1.07% 23
2019
Q3 		$2.57M Sell
19,850
-8,631
-30% -$1.14M 1.15% 23
2019
Q2 		$3.97M Buy
28,481
+3,928
+16% +$544K 1.81% 17
2019
Q1 		$3.43M Sell
24,553
-1,008
-4% -$135K 1.65% 17
2018
Q4 		$3.3M Buy
+25,561
New +$3.57M 2.03% 14

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sargent Investment Group's JNJ Position: Q1 2026 in Review

Sargent Investment Group increased its Johnson & Johnson (JNJ) stake by 0.24% in Q1 2026, buying an estimated $18.2K and bringing the position to 33,131 shares worth $8.1M. The position accounts for 1.07% of the portfolio, ranked #22.

Sargent Investment Group first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sargent Investment Group held 33,131 shares of Johnson & Johnson worth $8.1M as of Q1 2026.
  • Sargent Investment Group bought 78 Johnson & Johnson shares in Q1 2026, an estimated $18.2K.
  • Johnson & Johnson made up 1.07% of Sargent Investment Group's portfolio in Q1 2026, its #22 holding.
  • Sargent Investment Group first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.